These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34253265)

  • 1. Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas.
    Wang IE; Yi S; Block RC; Mousa SA
    Nutr Res Rev; 2022 Dec; 35(2):295-307. PubMed ID: 34253265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
    Welty FK; Daher R; Garelnabi M
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):89-107. PubMed ID: 37916414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Effect of Omega-3 Fatty Acids on Platelet Inhibition by Antiplatelet Drugs In Vitro.
    Koutsaliaris IK; Pantazi D; Tsouka AN; Argyropoulou O; Tellis CC; Tselepis AD
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health.
    Djuricic I; Calder PC
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():383-406. PubMed ID: 36662586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and omega-3 fatty acid status interact in the prevention of cardiovascular diseases in Framingham Heart Study.
    Block RC; Shearer GC; Holub A; Tu XM; Mousa S; Brenna JT; Harris WS; Tintle N
    Prostaglandins Leukot Essent Fatty Acids; 2021 Jun; 169():102283. PubMed ID: 33964664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials.
    Huang L; Zhang F; Xu P; Zhou Y; Liu Y; Zhang H; Tan X; Ge X; Xu Y; Guo M; Long Y
    Adv Nutr; 2023 Jul; 14(4):629-636. PubMed ID: 37121469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products.
    Fialkow J
    Am J Cardiovasc Drugs; 2016 Aug; 16(4):229-239. PubMed ID: 27138439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
    Yee LD; Lester JL; Cole RM; Richardson JR; Hsu JC; Li Y; Lehman A; Belury MA; Clinton SK
    Am J Clin Nutr; 2010 May; 91(5):1185-94. PubMed ID: 20335550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
    Harris WS; Dayspring TD; Moran TJ
    Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic (DHA) as modulatory and anti-inflammatory agents in noncommunicable diet-related diseases - Reports from the last 10 years.
    Banaszak M; Dobrzyńska M; Kawka A; Górna I; Woźniak D; Przysławski J; Drzymała-Czyż S
    Clin Nutr ESPEN; 2024 Oct; 63():240-258. PubMed ID: 38980796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease-Possible Causes and Future Considerations.
    Michaeloudes C; Christodoulides S; Christodoulou P; Kyriakou TC; Patrikios I; Stephanou A
    Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice.
    Liu L; Hu Q; Wu H; Xue Y; Cai L; Fang M; Liu Z; Yao P; Wu Y; Gong Z
    J Nutr Biochem; 2016 Jun; 32():171-80. PubMed ID: 27142749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. n-3 fatty acids and cardiovascular disease.
    Breslow JL
    Am J Clin Nutr; 2006 Jun; 83(6 Suppl):1477S-1482S. PubMed ID: 16841857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
    Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
    Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial.
    Shaikh NA; Yantha J; Shaikh S; Rowe W; Laidlaw M; Cockerline C; Ali A; Holub B; Jackowski G
    Mol Cell Biochem; 2014 Nov; 396(1-2):9-22. PubMed ID: 25185754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of long-chain n-3 polyunsaturated fatty acid supplementation on tuberculosis in mice.
    Nienaber A; Ozturk M; Dolman RC; Zandberg L; Hayford FE; Brombacher F; Blaauw R; Smuts CM; Parihar SP; Malan L
    Prostaglandins Leukot Essent Fatty Acids; 2021 Jul; 170():102304. PubMed ID: 34082319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between dietary intake of omega-3 polyunsaturated fatty acids and all-cause and cardiovascular mortality among hypertensive adults: Results from NHANES 1999-2018.
    Chen H; Leng X; Liu S; Zeng Z; Huang F; Huang R; Zou Y; Xu Y
    Clin Nutr; 2023 Dec; 42(12):2434-2442. PubMed ID: 37871484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
    Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
    Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.